Results
1
Stocks where the price continues to rise after more than a year of consistent gains.
1 companies
RBC Bioscience
Market Cap: NT$284.8m
Manufactures and sells reagents and devices for life science and molecular diagnosis.
6848
NT$22.60
7D
22.2%
1Y
26.3%